Drug Profile
Evogliptin/metformin - Dong-A ST
Alternative Names: DA-1229_01; Sugamet; Sugamet SR Tab 5/1000mg; SUGAMET®XR Tablet 5/1000mgLatest Information Update: 24 Feb 2023
Price :
$50
*
At a glance
- Originator Dong-A ST
- Class Amides; Antihyperglycaemics; Biguanides; Fluorobenzenes; Piperazines; Small molecules
- Mechanism of Action AMP activated protein kinase stimulants; Dipeptidyl peptidase 4 inhibitors; Gluconeogenesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Type 2 diabetes mellitus
Most Recent Events
- 22 Feb 2023 Dong-A ST plans a phase-I trial in healthy volunteers in South Korea (PO) (NCT05739903)
- 02 Jul 2019 Chemical structure information added
- 05 Jan 2016 Registered for Type-2 diabetes mellitus in South Korea (PO)